相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease
Fabiane L. de Oliveira et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Off the Beaten Renin-Angiotensin-Aldosterone System Pathway: New Perspectives on Antiproteinuric Therapy
Judit Gordon et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2011)
Amiodarone Inhibits Trypanosoma cruzi Infection and Promotes Cardiac Cell Recovery with Gap Junction and Cytoskeleton Reassembly In Vitro
Daniel Adesse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease
G. A. DosReis
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2011)
TGF-β/TGF-β receptor system and its role in physiological and pathological conditions
Juan F. Santibanez et al.
CLINICAL SCIENCE (2011)
The Antisense Oligonucleotide Trabedersen (AP 12009) for the Targeted Inhibition of TGF-β2
Frank Jaschinski et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Exploring anti-TGF-ββ therapies in cancer and fibrosis
Lukas J. A. C. Hawinkels et al.
GROWTH FACTORS (2011)
Immunomodulatory and anti-fibrotic effects of ganglioside therapy on the cardiac chronic form of experimental Trypanosoma cruzi infection
Romina Andrea Cutrullis et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload
Norimichi Koitabashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Marcin Dobaczewski et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Immunoneuroendocrine alterations in patients with progressive forms of chronic Chagas disease
A. R. Perez et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Targeted therapy for high-grade glioma with the TGF-beta 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
U. Bogdahn et al.
NEURO-ONCOLOGY (2011)
Antitrypanosomal Therapy for Chronic Chagas' Disease
Caryn Bern
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
Mark J. Anderton et al.
TOXICOLOGIC PATHOLOGY (2011)
Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication
Yan Zhang et al.
CARDIOVASCULAR PATHOLOGY (2010)
Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction
Marcin Dobaczewski et al.
CIRCULATION RESEARCH (2010)
Chagas disease: changes in knowledge and management
Francois-Xavier Lescure et al.
LANCET INFECTIOUS DISEASES (2010)
The Centennial of the Discovery of Chagas Disease: Facing the Current Challenges
Joseli Lannes-Vieira et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Pharmacological Inhibition of Transforming Growth Factor β Signaling Decreases Infection and Prevents Heart Damage in Acute Chagas' Disease
Mariana C. Waghabi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Amiodarone and Itraconazole: A Rational Therapeutic Approach for the Treatment of Chronic Chagas' Disease
A. E. Paniz-Mondolfi et al.
CHEMOTHERAPY (2009)
Short treatment with the tumour necrosis factor-α blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation
A. R. Perez et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Transforming growth factor beta 1 (TGFβ1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients
Jose E. Calzada et al.
CYTOKINE (2009)
Strategies for TGF-β modulation: a review of recent patents
Dominique Bonafoux et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Functional IL-10 Gene Polymorphism Is Associated with Chagas Disease Cardiomyopathy
Germano C. Costa et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
The effects of nitric oxide on the immune system during Trypanosoma cruzi infection
Fredy R. S. Gutierrez et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
J. Antonio Marin-Neto et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification
Anis Rassi et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Gap junction reduction in cardiomyocytes following transforming growth factor- beta treatment and Trypanosoma cruzi infection
Mariana C. Waghabi et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage
Gabriela A. Medeiros et al.
MICROBES AND INFECTION (2009)
Remodelling of gap junctions and connexin expression in diseased myocardium
Nicholas J. Severs et al.
CARDIOVASCULAR RESEARCH (2008)
Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy
Tania C. Araujo-Jorge et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
M. Petersen et al.
KIDNEY INTERNATIONAL (2008)
Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations
Gerald J. Prud'homme
LABORATORY INVESTIGATION (2007)
TGF-β regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection
Diana L. Martin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
SB-431542, a transforming growth factor β inhibitor, impairs Trypanosoma cruzi infection in cardiomvocvtes and parasite cycle completion
Mariana C. Waghabi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pathogenesis of chronic Chagas heart disease
Jose Antonio Marin-Neto et al.
CIRCULATION (2007)
Inhibition of ALK5 signaling induces physeal dysplasia in rats
Kendall Frazier et al.
TOXICOLOGIC PATHOLOGY (2007)
Angiotensin II stimulates apoptosis via TGF-β1 signaling in ventricular cardiomyocytes of rat
D. Schroeder et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
The logic of TGFβ signaling
Joan Massague et al.
FEBS LETTERS (2006)
Fibrosis in heart disease:: understanding the role of transforming growth factor-β1 in cardiomyopathy, valvular disease and arrhythmia
R Khan et al.
IMMUNOLOGY (2006)
Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H-pyran-4-yl)benzamide (GW788388):: A potent, selective, and orally active transforming growth factor-β type I receptor inhibitor
F Gellibert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole
G Benaim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The complex pattern of SMAD signaling in the cardiovascular system
G Euler-Taimor et al.
CARDIOVASCULAR RESEARCH (2006)
Gap junctional communication in tissue inflammation and repair
M Chanson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3
S Pokharel et al.
CIRCULATION (2004)
Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-beta 1 gene expression but not prevention of mitochondrial dysfunction
JW Card et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Implication of transforming growth factor-β1 in chagas disease myocardiopathy
TC Araújo-Jorge et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor β levels in mice deficient in α2-macroglobulin
MC Waghabi et al.
INFECTION AND IMMUNITY (2002)
Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity:: SB-431542
NJ Laping et al.
MOLECULAR PHARMACOLOGY (2002)
Autocrine regulation of myocyte CA3 expression by VEGF
RC Pimentel et al.
CIRCULATION RESEARCH (2002)
Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice
Z Mallat et al.
CIRCULATION RESEARCH (2001)
Induction of cardiac fibrosis by transforming growth factor-beta(1)
PJ Lijnen et al.
MOLECULAR GENETICS AND METABOLISM (2000)
分享论文
